To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene GSRTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
266 supporting clones for gene GSR back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CB988964 Human Placenta, placenta .a 1 to 718 30 to 753   tiling clone,   724/789
(91 %)
9 diff
(98.9 %id)
BM148117 leukopheresis .a 30 to 526 1 to 497       497/497
(100 %)
2 diff
(99.6 %id)
DB501277 hypothalamus .a 67 to 559 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
DN997944 breast cancer, Mammary gland (cancer tissue) .a 72 to 348 1 to 277       277/277
(100 %)
4 diff
(98.6 %id)
BC069244 Lung, large cell carcinoma .a 74 to 1803 1 to 1730 exact tiling clone, available from MGC, AAA   1730/1730
(100 %)
0 diff
(100 %id)
NM_000637.2   .a 74 to 2335 1 to 2262 exact RefSeq,   2262/2262
(100 %)
0 diff
(100 %id)
BQ673595 epidermoid carcinoma, cell line, salivary gland .a 75 to 474 1 to 400       400/1225
(32 %)
4 diff
(99.7 %id)
BQ954745 large cell carcinoma, lung .a 75 to 925 1 to 863       860/875
(98 %)
15 diff
(98.3 %id)
CR603039 HeLa cells Cot 25-normalized .a 157 to 1760 1 to 1604 exact     1604/1604
(100 %)
0 diff
(100 %id)
BX341805   .a 157 to 890 1 to 735   fully sequenced,   735/735
(100 %)
4 diff
(99.5 %id)
TI_1948234866   .a 163 to 995 133 to 969   fully sequenced,   837/969
(86 %)
20 diff
(98.0 %id)
TI_1948235202   .a 163 to 990 136 to 968   fully sequenced,   833/968
(86 %)
4 diff
(99.6 %id)
TI_1948235224   .a 163 to 866 131 to 838       708/1300
(54 %)
19 diff
(98.6 %id)
AF228704   .a 165 to 1807 1 to 1643 exact     1643/1643
(100 %)
0 diff
(100 %id)
EL736564 mixed .a 165 to 739 1 to 576       576/576
(100 %)
7 diff
(98.8 %id)
CB960944 Human Placenta, placenta .a 165 to 658 28 to 519       492/854
(57 %)
3 diff
(99.7 %id)
CR995696 T-Lymphocytes .a 167 to 848 1 to 682       682/684
(99 %)
1 diff
(99.9 %id)
CT002786 T-Lymphocytes .a 176 to 874 1 to 700       700/700
(100 %)
3 diff
(99.6 %id)
BQ225447 brain .a 181 to 925 1 to 757       757/817
(92 %)
17 diff
(98.0 %id)
BU508076 leiomyosarcoma, uterus .a 181 to 592 1 to 414       412/1211
(34 %)
15 diff
(98.8 %id)
X15722 placenta .a 188 to 1807 1 to 1618       1618/1618
(100 %)
2 diff
(99.9 %id)
BX458329 placenta .a 206 to 1146 1 to 940       940/940
(100 %)
2 diff
(99.8 %id)
DR006778 Spleen .a 212 to 943 1 to 732       732/732
(100 %)
4 diff
(99.5 %id)
BX396017 Placenta Cot 25-normalized .a 213 to 1198 23 to 1006       984/1012
(97 %)
3 diff
(99.8 %id)
BY994040   .a 214 to 926 17 to 729       713/729
(97 %)
0 diff
(100 %id)
BQ216251 large cell carcinoma, lung .a 253 to 1051 1 to 802       802/856
(93 %)
8 diff
(99.1 %id)
BM800375 leiomyosarcoma, uterus .a 254 to 960 5 to 719       724/1058
(68 %)
64 diff
(94.0 %id)
BU194797 melanotic melanoma, skin .a 257 to 1026 6 to 776       771/894
(86 %)
10 diff
(98.9 %id)
CB959816 Human Placenta, placenta .a 279 to 754 28 to 506       479/958
(50 %)
6 diff
(99.4 %id)
CF593279 Human Placenta, placenta .a 279 to 812 29 to 570       542/875
(61 %)
18 diff
(98.0 %id)
BM922873 leukocyte .a 284 to 1046 1 to 766   available from MGC,   766/987
(77 %)
37 diff
(96.3 %id)
BC035691 Blood, adult leukocytes .a 296 to 3186 1 to 2886   tiling clone, available from MGC, AAA   2886/2886
(100 %)
11 diff
(99.7 %id)
BX402221.
matches multiple genes
placenta, Placenta Cot 25-normalized .a 298 to 1077 1 to 779   fully sequenced, also hits gene C21orf63 779/779
(100 %)
1 diff
(99.9 %id)
BQ224655 melanotic melanoma, skin .a 298 to 1052 1 to 758       758/943
(80 %)
11 diff
(98.9 %id)
CA397018 eye, RPE/choroid .a 304 to 956 1 to 653       653/653
(100 %)
0 diff
(100 %id)
CA397102 eye, RPE/choroid .a 304 to 367 1 to 64       64/64
(100 %)
3 diff
(95.4 %id)
BX363048   .a 308 to 1197 1 to 887       887/894
(99 %)
4 diff
(99.6 %id)
DA996386   .a 315 to 841 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DA386384 thalamus .a 361 to 933 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AL121474 melanoma (MeWo cell line) .a 375 to 807 1 to 434       434/441
(98 %)
4 diff
(99.1 %id)
TI_154105804   .a 386 to 1197 8 to 811     Submitted on the opposite strand 804/1004
(80 %)
10 diff
(99.1 %id)
BP272119   .a 417 to 970 24 to 576       553/584
(94 %)
1 diff
(99.9 %id)
AI535810 Prostate .a 430 to 857 1 to 428     Submitted on the opposite strand 428/439
(97 %)
6 diff
(98.7 %id)
BQ436355 large cell carcinoma, lung .a 471 to 1316 1 to 850       850/851
(99 %)
6 diff
(99.3 %id)
AA777289 liver and spleen .a 491 to 1009 1 to 518     Submitted on the opposite strand 518/518
(100 %)
1 diff
(99.9 %id)
BQ335284 marrow .a 529 to 858 368 to 40       329/368
(89 %)
17 diff
(95.4 %id)
AW373445 breast .a 599 to 771 1 to 178       178/179
(99 %)
9 diff
(95.0 %id)
BQ377166 uterus .a 611 to 865 8 to 262       255/264
(96 %)
5 diff
(98.2 %id)
BM907259 large cell carcinoma, lung .a 615 to 1449 12 to 849       838/1002
(83 %)
28 diff
(97.3 %id)
BE181122 head_neck .a 627 to 838 13 to 222       210/222
(94 %)
1 diff
(99.6 %id)
BE710512 head_neck .a 634 to 838 16 to 219       204/219
(93 %)
1 diff
(99.6 %id)
BF037569 adenocarcinoma, ovary .a 677 to 1455 1 to 762       762/862
(88 %)
29 diff
(96.7 %id)
T29659 small intestine .a 698 to 1009 1 to 313       311/313
(99 %)
1 diff
(99.7 %id)
BM551887 melanotic melanoma, skin .a 712 to 1529 1 to 821       821/1059
(77 %)
27 diff
(97.5 %id)
BQ362729 stomach .a 766 to 1432 680 to 15       666/680
(97 %)
8 diff
(98.9 %id)
DA194219 amygdala .a 817 to 1388 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BX341804   .a 829 to 1760 931 to 1   fully sequenced,   931/931
(100 %)
2 diff
(99.8 %id)
TI_149300036   .a 878 to 1809 1001 to 77   AAA   925/967
(95 %)
20 diff
(98.0 %id)
TI_1948235203   .a 958 to 1732 903 to 129   fully sequenced,   775/903
(85 %)
8 diff
(99.2 %id)
TI_159705632   .a 960 to 1803 885 to 61   AAA   825/974
(84 %)
28 diff
(97.2 %id)
TI_1948234867   .a 965 to 1732 900 to 128   fully sequenced,   773/900
(85 %)
12 diff
(98.7 %id)
TI_159682299   .a 981 to 1803 882 to 82   AAA   801/940
(85 %)
24 diff
(97.5 %id)
AA574223 breast .a 1004 to 1559 1 to 550     Submitted on the opposite strand 550/550
(100 %)
12 diff
(97.9 %id)
BX402220.
matches multiple genes
placenta, Placenta Cot 25-normalized .a 1016 to 1774 761 to 1   fully sequenced, also hits gene C21orf63 761/761
(100 %)
5 diff
(99.4 %id)
CB266806 adipose .a 1045 to 1348 304 to 1     Submitted on the opposite strand 304/311
(97 %)
2 diff
(99.4 %id)
TI_159700872   .a 1047 to 1803 842 to 92   AAA   751/1012
(74 %)
6 diff
(99.5 %id)
BM976198 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1047 to 1809 779 to 17   AAA   763/764
(99 %)
2 diff
(99.8 %id)
BX400484   .a 1059 to 1772 713 to 1       713/715
(99 %)
27 diff
(96.3 %id)
TI_159715148   .a 1074 to 1809 833 to 106   AAA   728/948
(76 %)
9 diff
(99.1 %id)
BM478858 melanotic melanoma, skin .a 1092 to 2059 1 to 983       983/1133
(86 %)
34 diff
(97.0 %id)
BQ015920 lung, Metastatic Chondrosarcoma .a 1127 to 1809 694 to 17   AAA   678/678
(100 %)
5 diff
(99.3 %id)
BU615915 Bone, Subchondral Bone .a 1157 to 1809 669 to 19   AAA   651/654
(99 %)
2 diff
(99.7 %id)
BQ219915 large cell carcinoma, lung .a 1170 to 2079 85 to 1005       921/1011
(91 %)
43 diff
(95.8 %id)
BX373980   .a 1205 to 1762 576 to 21       556/745
(74 %)
8 diff
(99.0 %id)
BP282966 bone marrow .a 1257 to 1834 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
BP237589 Liver .a 1264 to 1879 1 to 616       616/616
(100 %)
6 diff
(99.1 %id)
TI_151704598   .a 1296 to 1803 598 to 91   AAA   508/961
(52 %)
0 diff
(100 %id)
BX344085 Placenta Cot 25-normalized .a 1330 to 2179 1 to 848   tiling clone,   848/848
(100 %)
7 diff
(99.2 %id)
CV337663 marrow .a 1335 to 1768 1 to 434       434/435
(99 %)
3 diff
(99.4 %id)
BG171500 hypernephroma, cell line, Kidney .a 1369 to 2099 1 to 730       730/932
(78 %)
22 diff
(97.7 %id)
CF142260 CNCAP(3)T-225 cell line, Prostate .a 1391 to 1647 8 to 264       257/264
(97 %)
1 diff
(99.7 %id)
TI_154173165   .a 1391 to 1974 78 to 652       575/621
(92 %)
44 diff
(93.0 %id)
AW950814   .a 1393 to 1693 5 to 305       301/305
(98 %)
8 diff
(97.4 %id)
T08637   .a 1399 to 1630 1 to 232       232/232
(100 %)
0 diff
(100 %id)
BQ372611 prostate_tumor .a 1457 to 1787 332 to 3       330/332
(99 %)
1 diff
(99.7 %id)
BM838919 Ascites, stomach .a 1468 to 1937 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
BM478942 melanotic melanoma, skin .a 1482 to 2292 13 to 826       814/1127
(72 %)
9 diff
(99.3 %id)
BQ302488 breast .a 1498 to 2015 534 to 18       517/539
(95 %)
7 diff
(98.8 %id)
BQ302487 breast .a 1501 to 2004 5 to 508       504/509
(99 %)
3 diff
(99.5 %id)
BQ302794 breast .a 1502 to 1945 6 to 449       444/449
(98 %)
5 diff
(98.9 %id)
BQ302795 breast .a 1513 to 1742 3 to 234       232/276
(84 %)
13 diff
(95.3 %id)
BQ303121 breast .a 1525 to 1956 27 to 465       439/465
(94 %)
22 diff
(95.3 %id)
BE893132 melanotic melanoma, skin .a 1527 to 2264 1 to 740       740/953
(77 %)
15 diff
(98.5 %id)
AW602775 breast .a 1529 to 1902 31 to 405       375/405
(92 %)
9 diff
(97.8 %id)
AA700398 liver and spleen .a 1544 to 1805 262 to 1       262/262
(100 %)
15 diff
(94.3 %id)
CF141470 CNCAP(3)T-225 cell line, Prostate .a 1577 to 2048 1 to 471       471/471
(100 %)
9 diff
(98.1 %id)
BG286504 bladder, transitional cell papilloma, cell line .a 1582 to 2147 74 to 631       558/913
(61 %)
23 diff
(97.5 %id)
TI_154172204   .a 1583 to 2184 79 to 688       610/619
(98 %)
33 diff
(94.7 %id)
BE898140 melanotic melanoma, skin .a 1613 to 1997 1 to 389       389/1033
(37 %)
7 diff
(99.4 %id)
BF037765 adenocarcinoma, ovary .a 1640 to 2131 1 to 489       489/716
(68 %)
19 diff
(97.4 %id)
AA393564   .a 1702 to 1775 74 to 1     Submitted on the opposite strand 74/74
(100 %)
0 diff
(100 %id)
BG033568 breast, mammary adenocarcinoma, cell line .a 1740 to 2418 28 to 717       690/836
(82 %)
43 diff
(94.9 %id)
BE889726 leiomyosarcoma, uterus .a 1820 to 2541 1 to 733       733/815
(89 %)
61 diff
(92.6 %id)
CF146706 CNCAP(3)T-225 cell line, Prostate .a 1838 to 2473 1 to 631       631/631
(100 %)
13 diff
(98.0 %id)
TI_154179213   .a 1844 to 2615 68 to 837       770/811
(94 %)
31 diff
(96.2 %id)
CD108017 brain, Pituitary .a 1860 to 2690 1 to 846       846/898
(94 %)
23 diff
(97.5 %id)
AL135513 melanoma (MeWo cell line) .a 1864 to 2382 1 to 519       519/519
(100 %)
7 diff
(98.7 %id)
AL135420 melanoma (MeWo cell line) .a 1864 to 2410 1 to 547       547/547
(100 %)
2 diff
(99.7 %id)
BY997252   .a 1895 to 2396 10 to 512       503/512
(98 %)
0 diff
(100 %id)
EC482033 Prostate .a 1956 to 2077 1 to 121       121/121
(100 %)
12 diff
(90.1 %id)
CK904292 Islets of Langerhans, Pancreas .a 1980 to 2562 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BM021453 Islets of Langerhans, Pancreas .a 1996 to 2508 1 to 514       514/514
(100 %)
2 diff
(99.7 %id)
CB215926 normal endometrium, late proliferativephase, cycle day 13, uterus .a 2000 to 2585 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
AJ708477 heart .a 2024 to 2092 1 to 69       69/69
(100 %)
1 diff
(98.6 %id)
EC564631 Prostate .a 2024 to 2093 1 to 68       68/73
(93 %)
3 diff
(95.9 %id)
EC500887 Prostate .a 2025 to 2143 1 to 112       112/112
(100 %)
3 diff
(97.4 %id)
BU943062 mixed (pool of 40 RNAs) .a 2076 to 2705 1 to 645       645/834
(77 %)
37 diff
(95.6 %id)
AL569344 placenta .a 2080 to 2798 1065 to 354     Submitted on the opposite strand 712/1201
(59 %)
83 diff
(93.1 %id)
CB069502 Pancreas, Purified pancreatic islet .a 2080 to 2464 1 to 385       385/385
(100 %)
12 diff
(96.9 %id)
AA188886   .a 2100 to 2450 1 to 352   tiling clone,   352/352
(100 %)
6 diff
(98.3 %id)
N53014 liver and spleen .a 2102 to 2445 1 to 350     Submitted on the opposite strand 350/354
(98 %)
14 diff
(96.1 %id)
AA846203 parathyroid gland, parathyroid tumor .a 2118 to 2573 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
BG574134 breast, mammary adenocarcinoma, cell line .a 2128 to 2717 1 to 590   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 590/590
(100 %)
6 diff
(99.0 %id)
BF805325 colon_ins .a 2136 to 2541 1 to 406       406/406
(100 %)
2 diff
(99.6 %id)
TI_227714758   .a 2153 to 3186 1082 to 62   AAA   1021/1025
(99 %)
35 diff
(96.6 %id)
BF343776 brain, glioblastoma with EGFR amplification .a 2169 to 2885 14 to 729       716/947
(75 %)
25 diff
(97.4 %id)
AW630914 2 pooled high-grade transitional celltumors, genitourinary tract .a 2184 to 2532 1 to 349   fully sequenced,   349/349
(100 %)
2 diff
(99.5 %id)
TI_149306687   .a 2187 to 3186 1070 to 88   AAA   983/1010
(97 %)
28 diff
(97.3 %id)
TI_159724026   .a 2190 to 3188 1066 to 85   AAA   982/1029
(95 %)
21 diff
(98.0 %id)
BU183075 melanotic melanoma, skin .a 2193 to 3042 1 to 857       857/885
(96 %)
17 diff
(98.1 %id)
TI_154062406   .a 2203 to 3186 1055 to 80   AAA   976/984
(99 %)
29 diff
(97.1 %id)
BG290066 bladder, transitional cell papilloma, cell line .a 2213 to 2809 1 to 628       628/703
(89 %)
44 diff
(93.8 %id)
BX398644 Placenta Cot 25-normalized .a 2219 to 3184 1 to 959       959/967
(99 %)
12 diff
(98.8 %id)
BM462960 melanotic melanoma, skin .a 2227 to 3189 24 to 983   AAA   960/983
(97 %)
0 diff
(100 %id)
AI568896 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2257 to 2717 462 to 1       462/462
(100 %)
3 diff
(99.4 %id)
TI_154181782   .a 2261 to 3108 953 to 111   AAA Submitted on the opposite strand 843/846
(99 %)
62 diff
(92.7 %id)
N24984 melanocyte .a 2267 to 2705 1 to 441       441/481
(91 %)
10 diff
(98.0 %id)
BM850239 stomach .a 2268 to 2576 1 to 309       309/309
(100 %)
4 diff
(98.8 %id)
TI_149274916   .a 2275 to 2899 682 to 58       625/1096
(57 %)
0 diff
(100 %id)
BU676403 lung, Primary Lung Epithelial Cells .a 2275 to 2893 619 to 1       619/634
(97 %)
7 diff
(98.9 %id)
R58530   .a 2286 to 2458 1 to 174       174/174
(100 %)
9 diff
(94.9 %id)
AW295627   .a 2327 to 2584 269 to 12   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 258/268
(96 %)
0 diff
(100 %id)
TI_149296445   .a 2367 to 3188 896 to 84   AAA   813/933
(87 %)
10 diff
(99.0 %id)
BM791158 stomach .a 2391 to 3003 1 to 605       605/605
(100 %)
5 diff
(99.2 %id)
AW793847 uterus .a 2404 to 2512 112 to 5       108/134
(80 %)
0 diff
(100 %id)
CB136194 Liver .a 2409 to 3030 1 to 618       618/618
(100 %)
9 diff
(98.6 %id)
BU684390 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2409 to 3188 792 to 17   AAA   776/776
(100 %)
5 diff
(99.4 %id)
TI_159683759   .a 2417 to 3332 995 to 95   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 901/1044
(86 %)
21 diff
(98.0 %id)
CV570871 cornea, eye .a 2439 to 3064 1 to 623       623/623
(100 %)
4 diff
(99.4 %id)
CF146663 CNCAP(3)T-225 cell line, Prostate .a 2445 to 3119 16 to 685       670/685
(97 %)
0 diff
(100 %id)
TI_154179151   .a 2445 to 3186 85 to 819   AAA   735/743
(98 %)
0 diff
(100 %id)
CF134978 CNCAP(3)T-225 cell line, Prostate .a 2448 to 2924 23 to 494       472/494
(95 %)
0 diff
(100 %id)
TI_154163145   .a 2448 to 3145 96 to 792       697/728
(95 %)
0 diff
(100 %id)
AI923246 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2452 to 2877 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
W56232 parathyroid gland, parathyroid tumor .a 2461 to 2856 1 to 398       398/398
(100 %)
5 diff
(98.8 %id)
CA944703 Human Lung Epithelial cells, lung .a 2462 to 3188 738 to 17   AAA   722/722
(100 %)
4 diff
(99.5 %id)
R27195 placenta .a 2463 to 2865 1 to 416     Submitted on the opposite strand 416/419
(99 %)
17 diff
(96.0 %id)
AA417617 germinal center B cell .a 2469 to 2850 1 to 382   fully sequenced,   382/382
(100 %)
1 diff
(99.8 %id)
R27344 placenta .a 2476 to 2907 1 to 435     Submitted on the opposite strand 435/435
(100 %)
6 diff
(98.7 %id)
BU618783 Cell Line, Chondrosarcoma .a 2480 to 3186 723 to 19   AAA   705/705
(100 %)
9 diff
(98.8 %id)
N28328 melanocyte .a 2481 to 2910 1 to 437       437/437
(100 %)
12 diff
(97.3 %id)
BP422018 small intestine .a 2487 to 3000 1 to 511     Submitted on the opposite strand 511/511
(100 %)
8 diff
(98.5 %id)
AW627632 2 pooled high-grade transitional celltumors, genitourinary tract .a 2502 to 2876 375 to 1   fully sequenced,   375/375
(100 %)
8 diff
(97.9 %id)
BG505389 embryonal carcinoma, testis .a 2507 to 3141 1 to 642       642/856
(75 %)
37 diff
(95.7 %id)
CD742706 Alveolar Macrophage, lung .a 2519 to 3186 683 to 19   AAA   665/665
(100 %)
5 diff
(99.3 %id)
CA421153 Bone, Enchondroma cell line .a 2520 to 3186 680 to 19   AAA   662/662
(100 %)
5 diff
(99.3 %id)
CB528732 Aveolar Macrophage, lung .a 2520 to 3186 682 to 19   AAA   664/664
(100 %)
2 diff
(99.7 %id)
AA369382 placenta .a 2534 to 2826 1 to 294       294/294
(100 %)
2 diff
(99.4 %id)
CK429833 eye, lacrimal gland .a 2539 to 3182 1 to 639       639/639
(100 %)
4 diff
(99.4 %id)
CA432321 cell lines, Chondrosarcoma .a 2550 to 3186 653 to 19   AAA   635/635
(100 %)
10 diff
(98.5 %id)
BU753579 placenta .a 2551 to 3186 656 to 18   AAA   639/639
(100 %)
8 diff
(98.8 %id)
BM978758 lung, Primary Lung Epithelial Cells .a 2552 to 3186 649 to 19   AAA   631/631
(100 %)
3 diff
(99.6 %id)
TI_154177451   .a 2561 to 3173 687 to 80     Submitted on the opposite strand 608/613
(99 %)
23 diff
(96.3 %id)
H85078 eye, retina .a 2571 to 2876 307 to 1     Submitted on the opposite strand 307/307
(100 %)
2 diff
(99.4 %id)
AW953867   .a 2573 to 3166 1 to 595       595/595
(100 %)
21 diff
(96.5 %id)
AW954039   .a 2573 to 3169 1 to 595       595/597
(99 %)
10 diff
(98.4 %id)
BM546714 ovary (pool of 3) .a 2575 to 3186 72 to 680   tiling clone,   609/1422
(42 %)
10 diff
(99.3 %id)
H85068 eye, retina .a 2583 to 2856 1 to 275     Submitted on the opposite strand 275/275
(100 %)
2 diff
(99.3 %id)
CF122263 CNCAP(3)T-225 cell line, Prostate .a 2606 to 3108 539 to 40   AAA Submitted on the opposite strand 500/500
(100 %)
22 diff
(95.6 %id)
AA317786 retina .a 2609 to 2945 1 to 333       333/333
(100 %)
5 diff
(98.5 %id)
BE784905 large cell carcinoma, lung .a 2623 to 2722 598 to 692       631/849
(74 %)
53 diff
(93.8 %id)
TI_154177228   .a 2629 to 3173 619 to 80     Submitted on the opposite strand 540/540
(100 %)
4 diff
(99.3 %id)
CA435011 lung, Metastatic Chondrosarcoma .a 2633 to 3186 571 to 19   AAA   553/565
(97 %)
1 diff
(99.9 %id)
AI888037 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2640 to 3188 544 to 1       544/544
(100 %)
5 diff
(99.1 %id)
AA777763 liver and spleen .a 2641 to 3186 543 to 1       543/543
(100 %)
3 diff
(99.5 %id)
TI_154177324   .a 2642 to 3173 606 to 80     Submitted on the opposite strand 527/625
(84 %)
7 diff
(98.9 %id)
CK904291 Islets of Langerhans, Pancreas .a 2649 to 3186 549 to 16   AAA   534/534
(100 %)
5 diff
(99.1 %id)
BX112378 liver and spleen .a 2654 to 3186 1 to 529   AAA   529/529
(100 %)
4 diff
(99.3 %id)
R05680 liver and spleen .a 2654 to 2924 1 to 275   fully sequenced,   275/275
(100 %)
15 diff
(94.6 %id)
AW778946 colon, moderately-differentiated adenocarcinoma .a 2665 to 3186 516 to 1       516/516
(100 %)
11 diff
(97.9 %id)
BM685493 eye, RPE and Choroid .a 2669 to 3174 1 to 501       501/501
(100 %)
14 diff
(97.3 %id)
CF145257 CNCAP(3)T-225 cell line, Prostate .a 2674 to 3173 502 to 8     Submitted on the opposite strand 495/502
(98 %)
3 diff
(99.5 %id)
CF145123 CNCAP(3)T-225 cell line, Prostate .a 2676 to 3173 500 to 8     Submitted on the opposite strand 493/500
(98 %)
3 diff
(99.4 %id)
AI569758 anaplastic oligodendroglioma, brain .a 2677 to 3187 510 to 2       509/510
(99 %)
0 diff
(100 %id)
AI499427 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2677 to 3190 509 to 1       509/509
(100 %)
5 diff
(99.1 %id)
AA526290 normal prostate, Prostate .a 2680 to 3186 522 to 20   AAA   503/503
(100 %)
12 diff
(97.7 %id)
AA573906 colon, tumor .a 2684 to 3192 504 to 1       504/504
(100 %)
5 diff
(99.1 %id)
BF060656 pooled .a 2686 to 3186 509 to 14   AAA   496/496
(100 %)
6 diff
(98.8 %id)
BE466396 pooled germ cell tumors .a 2709 to 3191 479 to 1       479/479
(100 %)
7 diff
(98.6 %id)
BQ775076 Bone, Human Chondrosarcoma Cell Line .a 2716 to 3186 488 to 19   AAA   470/470
(100 %)
3 diff
(99.4 %id)
AW069026 bone marrow stroma .a 2724 to 3186 476 to 19   AAA   458/458
(100 %)
4 diff
(99.2 %id)
AW511528 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2724 to 3186 469 to 12   AAA   458/458
(100 %)
3 diff
(99.4 %id)
AW516094 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2726 to 3189 461 to 1       461/461
(100 %)
5 diff
(99.0 %id)
BE350929 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 2727 to 3188 457 to 1       457/457
(100 %)
6 diff
(98.7 %id)
BU753372 placenta .a 2727 to 3186 473 to 18   AAA   456/456
(100 %)
12 diff
(97.4 %id)
AW778861 colon, moderately-differentiated adenocarcinoma .a 2729 to 3186 452 to 1       452/454
(99 %)
6 diff
(98.7 %id)
AI458494 carcinoid, lung .a 2734 to 3186 452 to 1       452/452
(100 %)
7 diff
(98.5 %id)
CB047788 Prostate .a 2738 to 3186 477 to 32   AAA   446/455
(98 %)
2 diff
(99.6 %id)
BM021183 Islets of Langerhans, Pancreas .a 2738 to 3186 460 to 16   AAA   445/445
(100 %)
5 diff
(98.9 %id)
AI348375 carcinoid, lung .a 2748 to 3192 443 to 4       440/443
(99 %)
0 diff
(100 %id)
AW515242 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2765 to 3192 425 to 3       423/425
(99 %)
0 diff
(100 %id)
BU753371 placenta .a 2775 to 3186 425 to 18   AAA   408/408
(100 %)
7 diff
(98.3 %id)
AI743913 pooled .a 2777 to 3187 413 to 3       411/413
(99 %)
0 diff
(100 %id)
W32467 heart .a 2779 to 3035 1 to 253   fully sequenced,   253/253
(100 %)
4 diff
(98.5 %id)
CF145200 CNCAP(3)T-225 cell line, Prostate .a 2780 to 3173 396 to 8     Submitted on the opposite strand 389/396
(98 %)
3 diff
(99.3 %id)
AI167773 parathyroid gland, parathyroid tumor .a 2784 to 3186 414 to 15   AAA   400/400
(100 %)
2 diff
(99.5 %id)
AI167778 parathyroid gland, parathyroid tumor .a 2784 to 3186 412 to 13   AAA   400/400
(100 %)
2 diff
(99.5 %id)
AI340014 adenocarcinoma, colon .a 2784 to 3190 402 to 1       402/402
(100 %)
4 diff
(99.1 %id)
AI445272 colon, moderately-differentiated adenocarcinoma .a 2784 to 3189 400 to 1       400/400
(100 %)
6 diff
(98.5 %id)
AW591035 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2784 to 3187 399 to 1       399/399
(100 %)
4 diff
(99.0 %id)
R27343 placenta .a 2788 to 3186 407 to 14   AAA Submitted on the opposite strand 394/394
(100 %)
5 diff
(98.8 %id)
AW083699 esophagus, squamous cell carcinoma .a 2805 to 3186 383 to 1       383/383
(100 %)
2 diff
(99.5 %id)
AI017672 Kidney .a 2806 to 3190 382 to 1       382/382
(100 %)
6 diff
(98.5 %id)
AA846130 parathyroid gland, parathyroid tumor .a 2809 to 3186 386 to 14   AAA   373/373
(100 %)
4 diff
(99.0 %id)
AA890684 parathyroid gland, parathyroid tumor .a 2814 to 3035 217 to 1       217/217
(100 %)
6 diff
(97.3 %id)
AI031742 parathyroid gland, parathyroid tumor .a 2815 to 3186 380 to 14   AAA   367/367
(100 %)
6 diff
(98.4 %id)
AW305026 brain, three pooled meningiomas .a 2817 to 3332 510 to 1   tiling clone,   510/510
(100 %)
5 diff
(99.1 %id)
AA417618 germinal center B cell .a 2820 to 3188 370 to 1   fully sequenced,   370/370
(100 %)
1 diff
(99.8 %id)
AI130967 heart .a 2821 to 3187 367 to 1       367/367
(100 %)
0 diff
(100 %id)
AI051164 brain, glioblastoma (pooled) .a 2822 to 3190 371 to 1       371/371
(100 %)
7 diff
(98.2 %id)
AW514640 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2839 to 3190 349 to 1       349/349
(100 %)
7 diff
(98.0 %id)
AW166621 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2849 to 3186 334 to 1       334/334
(100 %)
4 diff
(98.9 %id)
AI918078 Prostate .a 2868 to 3190 321 to 1       321/321
(100 %)
7 diff
(97.9 %id)
BF435521 sciatic nerve .a 2875 to 3192 321 to 5   tiling clone,   317/321
(98 %)
0 diff
(100 %id)
BU753422 placenta .a 2876 to 3187 330 to 18   AAA   313/314
(99 %)
2 diff
(99.4 %id)
AW628654 pooled .a 2880 to 3190 311 to 1       311/312
(99 %)
2 diff
(99.4 %id)
AW474028 lymph node, lymphoma, follicular mixed small and largecell .a 2881 to 3186 319 to 14   AAA   306/306
(100 %)
2 diff
(99.4 %id)
AA148403.
matches multiple genes
uterus .a 2886 to 3192 309 to 3     Submitted on the opposite strand, also hits gene TRAF3IP2 307/309
(99 %)
0 diff
(100 %id)
AA532636 normal prostate, Prostate .a 2889 to 3190 302 to 1       302/574
(52 %)
4 diff
(99.4 %id)
AW471025 carcinoid, lung .a 2892 to 3187 297 to 1       297/308
(96 %)
9 diff
(97.1 %id)
T16495   .a 2893 to 3186 294 to 1       294/294
(100 %)
1 diff
(99.7 %id)
T35136 placenta .a 2893 to 3186 294 to 1       294/298
(98 %)
0 diff
(100 %id)
T99542.
matches multiple genes
liver and spleen .a 2894 to 3184 303 to 8     also hits gene kloswaby 296/303
(97 %)
0 diff
(100 %id)
R05681 liver and spleen .a 2894 to 3184 294 to 1   fully sequenced,   294/294
(100 %)
3 diff
(99.0 %id)
H98786 melanocyte .a 2894 to 3112 224 to 6       219/224
(97 %)
0 diff
(100 %id)
R27194 placenta .a 2895 to 3186 308 to 13   AAA Submitted on the opposite strand 296/296
(100 %)
6 diff
(98.0 %id)
CN294855 embryonic stem cells, DMSO-treated H9 cellline .a 2897 to 3186 300 to 11   AAA Submitted on the opposite strand 290/290
(100 %)
5 diff
(98.3 %id)
R27232 placenta .a 2897 to 3186 306 to 13   AAA Submitted on the opposite strand 294/294
(100 %)
7 diff
(97.7 %id)
AI203032 pooled germ cell tumors .a 2901 to 3188 287 to 1       287/287
(100 %)
1 diff
(99.7 %id)
C13971   .a 2903 to 3186 284 to 1       284/284
(100 %)
0 diff
(100 %id)
AA769735 2 pooled tumors (clear cell type), Kidney .a 2910 to 3191 282 to 1       282/282
(100 %)
4 diff
(98.6 %id)
BM971231 lung, Primary Lung Epithelial Cells .a 2943 to 3186 263 to 19   AAA   245/252
(97 %)
1 diff
(99.7 %id)
AA548433 normal prostatic epithelial cells, Prostate .a 2959 to 3183 9 to 233       225/252
(89 %)
3 diff
(98.9 %id)
BF439088 pooled .a 2982 to 3191 207 to 1       207/207
(100 %)
2 diff
(99.1 %id)
BX370025 Placenta Cot 25-normalized .a 2997 to 3192 1 to 194       194/198
(97 %)
10 diff
(95.0 %id)
W19830 heart .a 3005 to 3189 185 to 1   fully sequenced,   185/185
(100 %)
2 diff
(99.0 %id)
AA725383 parathyroid gland, parathyroid tumor .a 3030 to 3186 169 to 13   AAA   157/157
(100 %)
0 diff
(100 %id)
BM817856 stomach .a 3056 to 3186 1 to 131   AAA   131/131
(100 %)
0 diff
(100 %id)
AB519179   .b 1 to 1482 1 to 1482 exact tiling clone,   1482/1482
(100 %)
0 diff
(100 %id)
AB519180   .c 1 to 1410 1 to 1410 exact tiling clone,   1410/1410
(100 %)
0 diff
(100 %id)
AB519181   .d 1 to 1323 1 to 1323 exact tiling clone,   1323/1323
(100 %)
0 diff
(100 %id)
AL542274 placenta .e 1 to 1115 1 to 1104   tiling clone,   1104/1111
(99 %)
24 diff
(97.9 %id)
BQ056743 lymph, lymphoma, cell line .f 1 to 911 1 to 918 A158S L159S L160S T161Y P162S ... tiling clone,   918/998
(91 %)
18 diff
(98.2 %id)
CN431413 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1 to 601 1 to 601 K196Q tiling clone,   601/601
(100 %)
1 diff
(99.9 %id)
BP314204 mammary gland .h 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
AW449420   .i-u 1 to 314 331 to 18 exact tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 314/314
(100 %)
0 diff
(100 %id)
CD695927 normal nasopharynx Gene GSR, variant not shown         Suspected internal deletion, this clone was ignored    
CR597200 B cells (Ramos cell line) Cot 25-normalized Gene GSR, variant not shown         Suspected internal deletion, this clone was ignored    
BX342743   Gene GSR, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
BX342744   Gene GSR, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
AI537097 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus Gene GSR, variant not shown         This clone was ignored    
AI949500 poorly differentiated adenocarcinoma withsignet ring cell features, stomach Gene GSR, variant not shown         This clone was ignored    
TI_1948235033   Gene GSR, variant not shown         This clone was ignored    
TI_1948235034   Gene GSR, variant not shown         This clone was ignored    
TI_1948235204   Gene GSR, variant not shown       fully sequenced, This clone was ignored    
TI_1948235205   Gene GSR, variant not shown       fully sequenced, This clone was ignored    
TI_1948235373   Gene GSR, variant not shown       fully sequenced, This clone was ignored    
TI_1948235374   Gene GSR, variant not shown       fully sequenced, This clone was ignored    
X54507   Gene GSR, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI